Atul Pande, Director at Immunovant, Inc. (IMVT), sold 7,750 shares at $28.54 ($221K) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Scheduled sale ($221k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IMVT | SELL | 2026-06-26 | $57K | — | Filing → |
| IMVT | SELL | 2026-06-16 | $51K | — | Filing → |
| IMVT | SELL | 2026-05-20 | $192K | — | Filing → |